Disclosures for "Serum Neurofilament Light Chain (sNfL) as Potential Biomarker for Immune Check Point Inhibitor (ICI) Mediated Limbic Encephalitis – A Case Series"
-
Dr. Zahid has nothing to disclose.
-
Dr. Tummala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REVHEALTH LLC.